Found: 1
Select item for more details and to access through your institution.
Female and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard‐dose azacitidine.
- Published in:
- Cancer Reports, 2024, v. 7, n. 1, p. 1, doi. 10.1002/cnr2.1938
- By:
- Publication type:
- Article